Nectar Lifesciences share news, announcements and annual reports
NSE: NECLIFEBSE: 532649Pharmaceuticals & BiotechnologySmall Cap
Nectar Lifesciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2005
Last close ₹10.20down ₹0.13 (1.26%)BSE ₹10.29
Share price at the NSE close on 30 Oct 2026. Previous close ₹10.33.
30 Oct: open ₹10.43, high ₹10.43, low ₹9.82
52-week range of traded prices to 30 Oct 2026
₹9.30Low, 30 Mar 2026₹22.40High, 23 Dec 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹198 Cr2,221st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −31.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹171 crore of one-off items, the largest of them in the quarter to Sep 2025.
- −9.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −15.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 95,05079.2% delivered
Nectar Lifesciences share news and announcements
590 announcements, routine notices left out, newest first. Page 9 of 12.
May 2015
Apr 2015
Mar 2015
Feb 2015
13 Feb · Results
4 Feb · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the company for the period ended on December 31, 2014.
Jan 2015
Dec 2014
30 Dec · Disclosure of Voting Pattern - Clause 35A
Nov 2014
12 Nov · Results
4 Nov · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial Results of the company for the period ended on September 30, 2014.
Oct 2014
1 Oct · Disclosure of Voting Pattern - Clause 35A
Sep 2014
30 Sep · Meeting
Members in their Annual General Meeting held on September 30, 2014 have declared the Final Dividend of Re. 0.10/- per equity share ( 10% on the face value of Re.1/- per equity share) for the financial year 2013-14. The Dividend will be paid latest by October 28, 2014.
Aug 2014
11 Aug · Meeting
Company has fixed Book Closure from August 23, 2014 to August 31, 2014 (both days inclusive) for the purpose of Annual General Meeting scheduled to be held on September 30, 2014 and Dividend, if any.11 Aug · Results
11 Aug · Management
Export Import Bank of India has appointed Ms. Rima Marphatia as their nominee director on the Board of Directors of the company. The appointment of Ms. Rima Marphatia is also satisfy the requirement of appointment of woman director on the Board as per section 149 (1) of the Companies Act, 2013.
Jul 2014
Jun 2014
9 Jun · News Verification
News Verification : The media had reports that "Nectar Life Put on Sale. Promoters Eye 20-25 % Premium". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. has vide its letter inter-alia stated, " We have not been informed or are aware on the rumored stake sale by Promoters of the Company."
May 2014
28 May · Results
19 May · Board meeting
To consider and approve, inter alia amongst items,: 1. The Audited Financial Results for Financial Year 2013-14, Balance Sheet of the company as at 31.03.2014 and Profit & Loss Accounts for the financial year ended on 31.03.2014 and matters related thereto. 2. Recommendation of final dividend to the Members of the company for Financial Year 2013-14.19 May · Updates
Trading window of the Company shall stand closed from May 21, 2014 i.e 7 days prior to the declaration of the financial results and recommendation of Dividend of the Company for the year ended March 31, 2014 and shall remain closed upto May 30, 2014 i.e 24 hours after publication of the said results and dividend.
Mar 2014
Feb 2014
11 Feb · Results
3 Feb · Updates
Trading window of the Company shall stand closed from February 04, 2014 i.e 7 days prior to the declaration of the quarterly financial results of the Company on February 11, 2014 and shall remain closed upto February 13, 2014 i.e 24 hours after publication of the said results.
Nov 2013
13 Nov · Results
5 Nov · Board meeting
To consider, inter alia amongst other items, the Unaudited Financial (Provisional) Results of the company for the quarter/ half year ended on September 30, 2013.
Oct 2013
15 Oct · Management
Board of Directors through resolution by circulation, on October 14, 2013 have appointed Mr. Dinesh Dua on the Board as an Additional Director as well as Wholetime Director (designated as Chief Executive Officer) for a period of 5 years w.e.f October 14, 2013, subject to the approval of shareholders in their General Meeting.
Sep 2013
30 Sep · Disclosure of Voting Pattern - Clause 35A
30 Sep · Meeting
Proceedings of Annual General Meeting held on September 30, 2013: 1. Adoption of Audited Financial statements for the year 2012-13 together with Directors and Auditors Reports thereon. 2. Declaration of Final Dividend @ 10% i.e. Re. 0.10/- per Equity Share. 3. Re-appointment of Mr. Vijay J. Shah as Director after retirement by rotation. 4. Re-appointment of Mr. Ajay Swaroop as Director after retirement by rotation. 5. Re-appointment M/s Datta Singla & Company, Chartered Accountants as Statutory Auditors of the Company. 6. Appointment of Mr. H.P. Singh as Director of the company. 7. Appointment of Mr. H.P.Singh as Director & President (Operations) and fix his remuneration.30 Sep · Dividend
Members in their Annual General Meeting held on September 30, 2013 have declared the Final Dividend of Re. 0.10/- per equity share ( 10% on the face value of Re. 1/- per equity share) for the financial year 2012-13. The Dividend will be paid latest by October 29, 2013.
Aug 2013
13 Aug · Results
13 Aug · Meeting
Company has fixed Book Closure from September 21, 2013 to September 30, 2013 for the purpose of Annual General Meeting scheduled to be held on September 30, 2013 & Dividend.5 Aug · Board meeting
To consider and approve, inter alia amongst items : (1) The Unaudited Financial Results of the company for the quarter ended on June 30, 2013; (2) To convene the Annual General Meeting of Members of the Company for the Financial Year 2012-13 and matters related thereto; (3) To fix the Book closure dates and for the purpose of Annual General Meeting and Dividend, as recommended by the Board Directors in their last Meeting.